BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15050737)

  • 1. Exon skipping of midkine pre-mRNA is enhanced by intronic polymorphism in a colon cancer cell line.
    Nobata S; Mogi H; Shinozawa T
    Cancer Lett; 2004 Apr; 207(1):89-93. PubMed ID: 15050737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
    Rouer E; Brule F; Benarous R
    Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
    Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
    Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
    Weng J; Ma W; Mitchell D; Zhang J; Liu M
    J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
    Yoshida K; Bolodeoku J; Sugino T; Goodison S; Matsumura Y; Warren BF; Toge T; Tahara E; Tarin D
    Cancer Res; 1995 Oct; 55(19):4273-7. PubMed ID: 7545538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of c-myb exon 9 induced by insertion of repeats.
    Shinagawa T; Ishiguro N; Horiuchi M; Matsui T; Okada K; Shinagawa M
    Oncogene; 1997 Jun; 14(23):2775-83. PubMed ID: 9190893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
    Li Y; Chen Z
    Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH.
    Duponchel C; Djenouhat K; Frémeaux-Bacchi V; Monnier N; Drouet C; Tosi M
    Hum Mutat; 2006 Mar; 27(3):295-6. PubMed ID: 16470590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of mouse muscle-type phosphofructokinase gene introns 10 and 11 with special reference to the exon skipping.
    Yamasaki T; Nakajima H; Hamaguchi T; Tomita K; Kono N; Yamada K; Noguchi T
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():97-101. PubMed ID: 17564308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
    Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
    Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
    Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
    Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence, linkage mapping and early developmental expression of the intestinal-type fatty acid-binding protein gene (fabp2) from zebrafish (Danio rerio).
    Sharma MK; Denovan-Wright EM; Degrave A; Thisse C; Thisse B; Wright JM
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Aug; 138(4):391-8. PubMed ID: 15325340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon skipping of exonuclease 1 in MRL/MpJ mice is caused by a nucleotide substitution of the branchpoint sequence in intron eight.
    Namiki Y; Kon Y; Sasaki N; Agui T; Endoh D
    Jpn J Vet Res; 2004 Nov; 52(3):125-34. PubMed ID: 15631010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
    Saebøe-Larssen S; Fossberg E; Gaudernack G
    BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
    Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
    Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenes.
    Gámez-Pozo A; Palacios I; Kontic M; Menéndez I; Camino I; García-Miguel P; Abelairas J; Pestaña A; Alonso J
    Hum Mutat; 2007 Dec; 28(12):1245. PubMed ID: 18000883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.